Participating Faculty: Management Strategies for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)

Faculty

Naim Alkhouri, MD, FAASLD
Chief Medical Officer
Chief of Transplant Hepatology
Director, Fatty Liver Program
Arizona Liver Health
Phoenix, AZ

Mazen Noureddin, MD, MHSc
Professor of Medicine, Academic Institute
Full Clinical Member, Research Institute
Houston Medical Hospital
Houston Research Institute
Houston, TX

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Naim Alkhouri, MD, FAASLD
CONSULTANCIES OR PAID ADVISORY BOARDS
Echosens; Fibronostics; Gilead Sciences, Inc; Intercept Pharmaceuticals, Inc; Madrigal Pharmaceuticals; Novo Nordisk; Viking Therapeutics; Zydus Pharmaceuticals, Inc.

GRANTS RECEIVED
89Bio, Inc; Boehringer Ingelheim; Gilead Sciences, Inc; Intercept Pharmaceuticals, Inc; Ionis Pharmaceuticals, Inc; Madrigal Pharmaceuticals; Novo Nordisk; Viking Therapeutics; Zydus Pharmaceuticals, Inc.

LECTURE FEES FOR SPEAKING AT THE
INVITATION OF A COMMERCIAL SPONSOR
Echosens; Gilead Sciences, Inc; Intercept Pharmaceuticals, Inc.

Mazen Noureddin, MD, MHSc

CONSULTANCIES OR PAID ADVISORY BOARDS
Altimmune; Aligos Therapeutics; AstraZeneca; Boehringer Ingelheim; Boston Pharmaceuticals; CytoDyn Inc; GSK plc; Lilly; Madrigal Pharmaceuticals; Merck & Co, Inc; Novo Nordisk; Takeda Pharmaceutical Company Limited; Terns Pharmaceuticals, Inc.

LECTURE FEES FOR SPEAKING AT THE
INVITATION OF A COMMERCIAL SPONSOR
Madrigal Pharmaceuticals.

STOCK OWNERSHIP
ChronWell; CytoDyn Inc; Rivus Pharmaceuticals.

PRINCIPAL INVESTIGATOR FOR A DRUG STUDY
Akero Therapeutics, Inc; Allergan Pharmaceuticals; Boehringer Ingelheim; Bristol
Myers Squibb; Conatus Pharma; Corcept Therapeutics, Inc; Enanta Pharmaceuticals, Inc; Gilead Sciences, Inc; Galectin Therapeutics; Genfit; GSK plc; Madrigal Pharmaceuticals; Novartis; Novo Nordisk; Takeda Pharmaceutical
Company Limited; Terns Pharmaceuticals, Inc; Viking Therapeutics; Zydus Pharmaceuticals, Inc.